Why Genuine Novo Nordisk Matters for Your Conversion
Understanding the Wegovy to Mounjaro Conversion Chart Essentials
Creating an accurate wegovy to mounjaro conversion chart requires understanding fundamental differences between these prescription-only medicines. Wegovy contains semaglutide, a GLP-1 receptor agonist manufactured exclusively by Novo Nordisk, whilst Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist from Eli Lilly. The wegovy to mounjaro conversion chart shows Wegovy's five-dose escalation (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) compared to Mounjaro's four-dose schedule (2.5mg, 5mg, 7.5mg, 10mg).
When examining any wegovy to mounjaro conversion chart, patients must recognise these aren't direct equivalents but rather different treatment approaches. EverydayMeds supplies only genuine Novo Nordisk Wegovy, sourced through licensed UK wholesalers and registered with our GPhC #9012878 pharmacy credentials. Every pen includes verifiable batch numbers, authentic FlexTouch branding, and temperature-controlled delivery ensuring medication integrity throughout your treatment journey.
Genuine Novo Nordisk Pricing and Value Protection
Our wegovy to mounjaro conversion chart includes transparent pricing for authentic Novo Nordisk products, starting with 0.25mg Wegovy at £79.99 and progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg (£209.99). New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. Our Intro Duo bundle (0.25mg & 0.5mg) provides convenient two-pen starter supply for £169.99, eliminating multiple ordering requirements.
The wegovy to mounjaro conversion chart reveals cost considerations beyond initial pricing, including storage flexibility and prescription requirements. Our Progress Trio bundle combines 0.5mg, 1mg, and 1.7mg doses for £369.99, supporting smooth dose escalation throughout your treatment transition. Both medications require ongoing prescriber oversight, but our streamlined 3-minute clinical assessment and standard 3-day prescriber review (or express 24-hour option) ensures minimal treatment interruption during any conversion process.
Clinical Evidence Supporting Wegovy to Mounjaro Conversion Chart Decisions
The wegovy to mounjaro conversion chart must be interpreted alongside clinical evidence from respective trials, though direct head-to-head comparisons aren't available due to different study designs and populations. Wegovy demonstrated significant results in the STEP programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). These results informed NICE TA875 recommendations for specialist weight management support.
Any wegovy to mounjaro conversion chart should acknowledge that switching between treatments requires individual clinical assessment rather than simple dose translation. Both medications work through appetite regulation mechanisms, though Mounjaro's dual receptor activation differs from Wegovy's GLP-1-specific action. EverydayMeds clinical team reviews each prescription request individually, ensuring appropriate dosing recommendations align with current treatment history and clinical presentation.
Mechanism Differences in Your Wegovy to Mounjaro Conversion Chart
Understanding your wegovy to mounjaro conversion chart requires recognising how Wegovy functions as a GLP-1 receptor agonist, mimicking natural incretin hormones that regulate blood sugar and appetite. Semaglutide binds specifically to GLP-1 receptors in the brain's appetite centres, promoting satiety after smaller meals and potentially reducing food cravings between eating occasions. This mechanism supports weight management when combined with reduced-calorie diet and increased physical activity, as required by MHRA licensing conditions. The once-weekly injection schedule maintains consistent therapeutic levels throughout treatment duration. Wegovy's specific receptor binding profile differs from Mounjaro's dual-action approach, making direct conversion calculations inappropriate without prescriber guidance.
Streamlined Ordering Process for Genuine Wegovy
Accessing genuine Novo Nordisk Wegovy through our wegovy to mounjaro conversion chart service begins with our comprehensive 3-minute online clinical assessment, covering medical history, current medications, and treatment goals. Our qualified prescribers review each application within 3 working days (or 24 hours with express service), ensuring appropriate clinical oversight for this prescription-only medicine. Once approved, next-day cold-chain delivery maintains medication integrity from our temperature-controlled facilities to your door. Our GPhC #9012878 registered pharmacy credentials assurance legitimate supply chain management throughout the ordering process. Patient support continues post-delivery with clinical guidance available for dose escalation timing and injection technique optimisation.
Storage and Practical Considerations in Wegovy to Mounjaro Conversion
The wegovy to mounjaro conversion chart includes important storage differences affecting treatment convenience and travel flexibility. Genuine Novo Nordisk Wegovy maintains stability for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Pre-filled FlexTouch pens require refrigerated storage at 2-8°C before first use, with each pen containing four weekly doses at prescribed strength. Dose escalation follows mandatory schedule progression, starting at 0.25mg for weeks 1-4, advancing through 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), reaching maintenance 2.4mg from week 17 onwards. Temperature monitoring during delivery and storage ensures medication potency throughout your treatment course.
Authenticity Verification for Your Wegovy to Mounjaro Conversion Chart
Counterfeit semaglutide products pose significant safety risks, making genuine Novo Nordisk verification essential when consulting any wegovy to mounjaro conversion chart. MHRA warnings highlight fake products containing incorrect active ingredients, contaminated substances, or inadequate sterility controls. Authentic Wegovy pens display clear batch numbers, genuine FlexTouch mechanism operation, and proper Novo Nordisk packaging with unbroken security seals.
EverydayMeds exclusively sources through licensed UK wholesalers, providing complete batch traceability and regulatory compliance documentation. Every wegovy to mounjaro conversion chart consultation includes verification guidance, helping patients identify authentic products versus dangerous counterfeits. Our temperature-controlled supply chain maintains cold-chain integrity from manufacturer through final delivery, ensuring therapeutic efficacy and patient safety throughout treatment duration.
Expert Consultation and Treatment Transition Support
Converting between weight management medications requires expert clinical oversight beyond simple wegovy to mounjaro conversion chart reference. Our qualified prescribers assess individual patient factors including previous treatment response, concurrent medications, medical history, and specific weight management goals before recommending appropriate dosing strategies. Both Wegovy and Mounjaro are available through EverydayMeds, allowing prescriber flexibility in selecting optimal treatment approaches for each patient's circumstances. New customers benefit from code FIRST40 applied at checkout, whilst returning patients use DOSE25 for continued access to genuine medications. Contact our clinical team through https://everydaymeds.co.uk/collections/wegovy for personalised guidance on treatment options and conversion protocols. Treatment success depends on combining prescription medication with sustained lifestyle modifications including reduced-calorie diet and increased physical activity as required by MHRA licensing conditions.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
